Authors
Loading...
Analysis reveals improved CLL risk stratification using germline variations and somatic mutations in large cohorts, suggesting better clinical decision-making.
Hubbard et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: